$RYAN

RYAN SPECIALTY HOLDINGS, INC.

No enriched coverage for $RYAN in the last 7 days.

No SEC Form 4 filings for $RYAN in the last 30 days.

See all $RYAN insider activity →
Med

RYAN Maintained by Wells Fargo -- Price Target Lowered to $41.00

Wells Fargo maintained an 'Equal-Weight' rating for Ryan Specialty Holdings (RYAN) but lowered its price target to $41.00. The stock is currently trading at $37.12, with a GF Value™ of $82.86, suggesting a 55.2% undervaluation. The company has a GF Score™ of 78/100, indicating strong growth and profitability but concerns about valuation. Insider selling and mixed guru activity add to the cautious outlook.

RYAN sentiment & insider activity

Recent RYAN coverage spans financial news, earnings and insider activity.

What's driving RYAN

AlphAI scores every news story that mentions RYAN with an AI model for sentiment and relevance, and aggregates insider trades from RYAN SPECIALTY HOLDINGS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $RYAN

Score
$RYANMed

RYAN Maintained by Wells Fargo -- Price Target Lowered to $41.00

Wells Fargo maintained an 'Equal-Weight' rating for Ryan Specialty Holdings (RYAN) but lowered its price target to $41.00. The stock is currently trading at $37.12, with a GF Value™ of $82.86, suggesting a 55.2% undervaluation. The company has a GF Score™ of 78/100, indicating strong growth and profitability but concerns about valuation. Insider selling and mixed guru activity add to the cautious outlook.

$RYANLow

Ryan Specialty Shares Gain 9% in 3 Months: What's Driving the Rally?

Ryan Specialty Holdings' shares rose 9% in 3 months, outperforming the industry and S&P 500. The rally was driven by index inclusion, better-than-expected Q2 results, improved margin outlook, and capital returns. The company reported 74 cents adjusted EPS, up 12.1% YoY, and raised its 2026 EBITDAC margin guidance. It also expanded underwriting capabilities and repurchased shares worth $260 million. Analysts expect 11.2% EPS growth in 2026.

RYAN SPECIALTY HOLDINGS, INC. (RYAN): Entry into a Material Definitive Agreement

RYAN SPECIALTY HOLDINGS, INC. (RYAN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement . On August 4, 2026, Ryan Specialty Holdings, Inc. (the “Company”) and the Ryan Stock Option Trust (the “Trust”), a trust of which Patrick G. Ryan, the Company’s Executive Chairman, and Shirley W. Ryan, serve as trustees, enter

Ryan Specialty's Tera launches insurance programme for industrial

Ryan Specialty Underwriting Managers (RSUM) launched Tera Underwriters, a managing general underwriter, and a specialty insurance programme for computing hardware infrastructure in US industrial-scale data centres. The programme can provide over $1 billion per policy via a $625 million lead binder plus excess capital, backed by A+-rated capital, available through RT Specialty. Expansion internationally is planned for Q4 2026.

Ryan Specialty (RYAN) Stock Faces Margin Pressure Behind A 57.7x P/E

Simply Wall St reports Ryan Specialty Holdings (NYSE:RYAN) stock was about flat at $44.16 after a 90-day run. It cites Q2 organic revenue of about $917m and adjusted EPS of $0.74, alongside a 57.7x P/E. The article highlights margin pressure, with adjusted EBITDAC margin at 35.7% and guidance for a 50 to 100 bps full-year decline.

Vulcan Value Partners is Bullish on Ryan Specialty Holdings (RYAN)

Vulcan Value Partners’ Q2 2026 investor letter highlighted Ryan Specialty Holdings (NYSE:RYAN). The firm cited 11.8% Q1 organic revenue growth but said Ryan cut its 2026 organic revenue outlook to mid-single-digit from high-single-digit. Vulcan noted robust E&S submission growth despite 25% to 35% property rate declines, plus a $300MM share repurchase authorization increase. RYAN closed at $44.09 on July 30, 2026.

Related tickers